Literature DB >> 26835492

Imaging texture analysis for automated prediction of lung cancer recurrence after stereotactic radiotherapy.

Sarah A Mattonen1, Shyama Tetar2, David A Palma3, Alexander V Louie4, Suresh Senan2, Aaron D Ward1.   

Abstract

Benign radiation-induced lung injury (RILI) is not uncommon following stereotactic ablative radiotherapy (SABR) for lung cancer and can be difficult to differentiate from tumor recurrence on follow-up imaging. We previously showed the ability of computed tomography (CT) texture analysis to predict recurrence. The aim of this study was to evaluate and compare the accuracy of recurrence prediction using manual region-of-interest segmentation to that of a semiautomatic approach. We analyzed 22 patients treated for 24 lesions (11 recurrences, 13 RILI). Consolidative and ground-glass opacity (GGO) regions were manually delineated. The longest axial diameter of the consolidative region on each post-SABR CT image was measured. This line segment is routinely obtained as part of the clinical imaging workflow and was used as input to automatically delineate the consolidative region and subsequently derive a periconsolidative region to sample GGO tissue. Texture features were calculated, and at two to five months post-SABR, the entropy texture measure within the semiautomatic segmentations showed prediction accuracies [areas under the receiver operating characteristic curve (AUC): 0.70 to 0.73] similar to those of manual GGO segmentations (AUC: 0.64). After integration into the clinical workflow, this decision support system has the potential to support earlier salvage for patients with recurrence and fewer investigations of benign RILI.

Entities:  

Keywords:  computed tomography; lung cancer; radiomics; recurrence; stereotactic radiation therapy; texture analysis

Year:  2015        PMID: 26835492      PMCID: PMC4718517          DOI: 10.1117/1.JMI.2.4.041010

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  31 in total

1.  Engineering and algorithm design for an image processing Api: a technical report on ITK--the Insight Toolkit.

Authors:  Terry S Yoo; Michael J Ackerman; William E Lorensen; Will Schroeder; Vikram Chalana; Stephen Aylward; Dimitris Metaxas; Ross Whitaker
Journal:  Stud Health Technol Inform       Date:  2002

2.  Automatic segmentation of lung parenchyma in the presence of diseases based on curvature of ribs.

Authors:  Mithun N Prasad; Matthew S Brown; Shama Ahmad; Fereidoun Abtin; Jared Allen; Irene da Costa; Hyun J Kim; Michael F McNitt-Gray; Jonathan G Goldin
Journal:  Acad Radiol       Date:  2008-09       Impact factor: 3.173

3.  2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Authors:  J Vansteenkiste; L Crinò; C Dooms; J Y Douillard; C Faivre-Finn; E Lim; G Rocco; S Senan; P Van Schil; G Veronesi; R Stahel; S Peters; E Felip
Journal:  Ann Oncol       Date:  2014-02-20       Impact factor: 32.976

4.  Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Authors:  Neal E Dunlap; Wensha Yang; Alyson McIntosh; Ke Sheng; Stanley H Benedict; Paul W Read; James M Larner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-14       Impact factor: 7.038

5.  Non-small cell lung cancer, version 1.2015.

Authors:  David S Ettinger; Douglas E Wood; Wallace Akerley; Lyudmila A Bazhenova; Hossein Borghaei; David Ross Camidge; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Thomas J Dilling; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Mark G Kris; Lee M Krug; Rudy P Lackner; Michael Lanuti; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Steven Schild; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2014-12       Impact factor: 11.908

6.  CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy.

Authors:  Brooke Sawyer; Emma Pun; Michael Samuel; Huilee Tay; Tomas Kron; Mathias Bressel; David Ball; Shankar Siva
Journal:  J Med Imaging Radiat Oncol       Date:  2015-01-20       Impact factor: 1.735

7.  Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era.

Authors:  Alexander V Louie; George Rodrigues; Jason Olsthoorn; David Palma; Edward Yu; Brian Yaremko; Belal Ahmad; Inge Aivas; Stewart Gaede
Journal:  Radiother Oncol       Date:  2010-02-01       Impact factor: 6.280

8.  Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.

Authors:  M Essler; J Wantke; B Mayer; K Scheidhauer; R A Bundschuh; B Haller; S T Astner; M Molls; N Andratschke
Journal:  Strahlenther Onkol       Date:  2013-04-24       Impact factor: 3.621

9.  Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer.

Authors:  David B Shultz; Nicholas Trakul; Jonathan A Abelson; James D Murphy; Peter G Maxim; Quynh-Thu Le; Billy W Loo; Maximilian Diehn
Journal:  Clin Lung Cancer       Date:  2014-01-24       Impact factor: 4.785

10.  Robust Initialization of Active Shape Models for Lung Segmentation in CT Scans: A Feature-Based Atlas Approach.

Authors:  Gurman Gill; Matthew Toews; Reinhard R Beichel
Journal:  Int J Biomed Imaging       Date:  2014-10-21
View more
  6 in total

Review 1.  Towards precision medicine: from quantitative imaging to radiomics.

Authors:  U Rajendra Acharya; Yuki Hagiwara; Vidya K Sudarshan; Wai Yee Chan; Kwan Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

2.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

3.  Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab.

Authors:  Valerio Nardone; Paolo Tini; Pierpaolo Pastina; Cirino Botta; Alfonso Reginelli; Salvatore Francesco Carbone; Rocco Giannicola; Grazia Calabrese; Carmela Tebala; Cesare Guida; Aldo Giudice; Vito Barbieri; Pierfrancesco Tassone; Pierosandro Tagliaferri; Salvatore Cappabianca; Rosanna Capasso; Amalia Luce; Michele Caraglia; Maria Antonietta Mazzei; Luigi Pirtoli; Pierpaolo Correale
Journal:  Oncol Lett       Date:  2019-12-16       Impact factor: 2.967

4.  Delta-radiomics increases multicentre reproducibility: a phantom study.

Authors:  Valerio Nardone; Alfonso Reginelli; Cesare Guida; Maria Paola Belfiore; Michelangelo Biondi; Maria Mormile; Fabrizio Banci Buonamici; Eugenio Di Giorgio; Marco Spadafora; Paolo Tini; Roberta Grassi; Luigi Pirtoli; Pierpaolo Correale; Salvatore Cappabianca; Roberto Grassi
Journal:  Med Oncol       Date:  2020-03-31       Impact factor: 3.064

5.  Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation.

Authors:  Hyun Jung Koo; Mi Young Kim; Ja Hwan Koo; Yu Sub Sung; Jiwon Jung; Sung-Han Kim; Chang-Min Choi; Hwa Jung Kim
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 6.  Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.

Authors:  Liting Shi; Yaoyao He; Zilong Yuan; Stanley Benedict; Richard Valicenti; Jianfeng Qiu; Yi Rong
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.